This inventor holds 2 USPTO granted patents. Top assignees: Bissendorf Peptide Gmbh, Pharma Biotechnologie Hannover Gmbh. Active years: 1989-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hanover, DE (1989)
- Hannover, DE (1993)
Company Filing History:
Years Active: 1989-1993
Title: Ekkehard Schmoll: Innovator in Medical Device Technology
Introduction
Ekkehard Schmoll is a notable inventor based in Hanover, Germany. He has made significant contributions to the field of medical technology, particularly in the development of devices aimed at treating solid tumors. With a total of 2 patents, his work reflects a commitment to advancing healthcare solutions.
Latest Patents
Schmoll's latest patents include a method and device for the local application and removal of active substances. This innovative device is designed to be positioned distally to a tumor, allowing for the collection of blood coming from the tumor. It consists of a catheter, a pump, and a second catheter that returns the blood into the body. The device features at least one container that allows blood to pass through while containing immobilized substances with a high affinity for the applied active substance. Another patent focuses on a device specifically for the removal of therapeutic substances that are locally applied against solid tumors, utilizing a similar catheter and pump system.
Career Highlights
Throughout his career, Ekkehard Schmoll has worked with several companies, including Bissendorf Peptide GmbH and Pharma Biotechnologie Hannover GmbH. His experience in these organizations has contributed to his expertise in medical device innovation.
Collaborations
Schmoll has collaborated with notable colleagues such as Hans-Joachim Schmoll and Edmund R. Lax. These partnerships have likely enriched his work and expanded the impact of his inventions.
Conclusion
Ekkehard Schmoll's contributions to medical technology through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence the development of effective treatments for solid tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile